FISIOMICS

The group integrates advanced bioinformatics tools and omics technologies to better understand the molecular processes underlying health and disease. Its activity focuses on combining genomic, transcriptomic, proteomic, and metabolomic data to gain a comprehensive view of biological mechanisms and identify new diagnostic or therapeutic targets. Through a translational and patient-oriented approach, the group collaborates closely with hospitals and clinical centers to ensure the transfer of research findings into medical practice. This multidisciplinary perspective has led to competitive projects and high-impact scientific publications. The group’s work contributes to the development of more personalized and predictive medicine, improving early diagnosis and monitoring of complex diseases, particularly kidney disorders. With a strong foundation in computational analysis and molecular experimentation, the group’s activity has significant biomedical and societal relevance.